In this large, 10 week observational study, adults with type 1 diabetes and insulin-treated type 2 diabetes undertook meticulous thrice-daily reporting of their daily functioning using the Hypo-METRICS app and wore blinded CGM. The gene discussed is INS; the disease is type 2 diabetes mellitus.